Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
uniQure Analyst Ratings and Price Targets | NASDAQ:QURE | Benzinga
uniQure NV has a consensus price target of $40.19 based on the ratings of 16 analysts. The high is $70 issued by HC Wainwright & Co. on May 29, 2025. The low is $20 issued by Mizuho on December 19, 2024. The 3 most-recent analyst ratings were released by Chardan Capital, HC Wainwright & Co., and Guggenheim on May 30, 2025, May 29, 2025, and May 12, 2025, respectively. With an average price target of $45.33 between Chardan Capital, HC Wainwright & Co., and Guggenheim, there's an implied 206.72% upside for uniQure NV from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Chardan Capital
HC Wainwright & Co.
Guggenheim
Wells Fargo
RBC Capital
1calculated from analyst ratings
Analyst Ratings for uniQure
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/30/2025 | Buy Now | 157.1% | Chardan Capital | Daniil Gataulin58% | $38 → $38 | Maintains | Buy | Get Alert |
| 05/29/2025 | Buy Now | 373.61% | HC Wainwright & Co. | Patrick Trucchio51% | $70 → $70 | Reiterates | Buy → Buy | Get Alert |
| 05/12/2025 | Buy Now | 89.45% | Guggenheim | Debjit Chattopadhyay55% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
| 05/12/2025 | Buy Now | 157.1% | Chardan Capital | Daniil Gataulin58% | $38 → $38 | Maintains | Buy | Get Alert |
| 05/06/2025 | Buy Now | 157.1% | Chardan Capital | Daniil Gataulin58% | $38 → $38 | Maintains | Buy | Get Alert |
| 04/21/2025 | Buy Now | 373.61% | HC Wainwright & Co. | Patrick Trucchio51% | $70 → $70 | Reiterates | Buy → Buy | Get Alert |
| 04/01/2025 | Buy Now | 157.1% | Chardan Capital | Daniil Gataulin58% | $27 → $38 | Maintains | Buy | Get Alert |
| 03/04/2025 | Buy Now | 373.61% | HC Wainwright & Co. | Patrick Trucchio51% | $70 → $70 | Reiterates | Buy → Buy | Get Alert |
| 02/28/2025 | Buy Now | 102.98% | Wells Fargo | Yanan Zhu43% | $35 → $30 | Maintains | Equal-Weight | Get Alert |
| 01/27/2025 | Buy Now | 373.61% | HC Wainwright & Co. | Patrick Trucchio51% | $25 → $70 | Maintains | Buy | Get Alert |
| 01/21/2025 | Buy Now | 62.38% | RBC Capital | Luca Issi45% | $24 → $24 | Reiterates | Outperform → Outperform | Get Alert |
| 12/19/2024 | Buy Now | 35.32% | Mizuho | Uy Ear62% | $7 → $20 | Maintains | Neutral | Get Alert |
| 12/16/2024 | Buy Now | 116.51% | Stifel | Paul Matteis45% | $12 → $32 | Maintains | Buy | Get Alert |
| 12/12/2024 | Buy Now | 35.32% | Goldman Sachs | Salveen Richter52% | $9 → $20 | Maintains | Neutral | Get Alert |
| 12/11/2024 | Buy Now | 197.7% | Leerink Partners | — | $26 → $44 | Maintains | Outperform | Get Alert |
| 12/11/2024 | Buy Now | — | Guggenheim | Debjit Chattopadhyay55% | — | Reiterates | Buy → Buy | Get Alert |
| 12/11/2024 | Buy Now | 35.32% | RBC Capital | Luca Issi45% | $14 → $20 | Maintains | Outperform | Get Alert |
| 12/10/2024 | Buy Now | 69.15% | HC Wainwright & Co. | Patrick Trucchio51% | $25 → $25 | Reiterates | Buy → Buy | Get Alert |
| 12/10/2024 | Buy Now | 251.83% | Raymond James | Danielle Brill43% | $20 → $52 | Upgrade | Outperform → Strong Buy | Get Alert |
| 12/10/2024 | Buy Now | 292.42% | Cantor Fitzgerald | Kristen Kluska72% | $28 → $58 | Maintains | Overweight | Get Alert |
| 11/06/2024 | Buy Now | 69.15% | HC Wainwright & Co. | Patrick Trucchio51% | $25 → $25 | Reiterates | Buy → Buy | Get Alert |
| 11/06/2024 | Buy Now | -39.11% | Goldman Sachs | Salveen Richter52% | $10 → $9 | Maintains | Neutral | Get Alert |
| 11/06/2024 | Buy Now | -5.28% | RBC Capital | Luca Issi45% | $16 → $14 | Maintains | Outperform | Get Alert |
| 11/06/2024 | Buy Now | 89.45% | Cantor Fitzgerald | Kristen Kluska72% | $28 → $28 | Reiterates | Overweight → Overweight | Get Alert |
| 10/10/2024 | Buy Now | 35.32% | Raymond James | Danielle Brill43% | → $20 | Reinstates | → Outperform | Get Alert |
| 09/20/2024 | Buy Now | 89.45% | Cantor Fitzgerald | Kristen Kluska72% | $28 → $28 | Reiterates | Overweight → Overweight | Get Alert |
| 08/20/2024 | Buy Now | 69.15% | HC Wainwright & Co. | Patrick Trucchio51% | $25 → $25 | Reiterates | Buy → Buy | Get Alert |
| 08/02/2024 | Buy Now | -32.34% | Goldman Sachs | Salveen Richter52% | $6 → $10 | Maintains | Neutral | Get Alert |
| 07/16/2024 | Buy Now | 62.38% | Cantor Fitzgerald | Kristen Kluska72% | $24 → $24 | Reiterates | Overweight → Overweight | Get Alert |
| 07/09/2024 | Buy Now | 69.15% | HC Wainwright & Co. | Patrick Trucchio51% | $25 → $25 | Reiterates | Buy → Buy | Get Alert |
| 05/08/2024 | Buy Now | 69.15% | HC Wainwright & Co. | Patrick Trucchio51% | $25 → $25 | Reiterates | Buy → Buy | Get Alert |
| 05/08/2024 | Buy Now | -59.4% | Mizuho | Uy Ear62% | $7 → $6 | Maintains | Neutral | Get Alert |
| 03/04/2024 | Buy Now | -52.64% | Mizuho | Uy Ear62% | $10 → $7 | Maintains | Neutral | Get Alert |
| 03/01/2024 | Buy Now | 69.15% | HC Wainwright & Co. | Patrick Trucchio51% | $30 → $25 | Maintains | Buy | Get Alert |
| 02/29/2024 | Buy Now | -45.87% | Goldman Sachs | Salveen Richter52% | $63 → $8 | Downgrade | Buy → Neutral | Get Alert |
| 01/19/2024 | Buy Now | 102.98% | HC Wainwright & Co. | Patrick Trucchio51% | $30 → $30 | Reiterates | Buy → Buy | Get Alert |
| 01/16/2024 | Buy Now | 89.45% | RBC Capital | Luca Issi45% | $28 → $28 | Reiterates | Outperform → Outperform | Get Alert |
| 12/20/2023 | Buy Now | 42.08% | Cantor Fitzgerald | Kristen Kluska72% | $21 → $21 | Reiterates | Overweight → Overweight | Get Alert |
| 12/19/2023 | Buy Now | -32.34% | Mizuho | Uy Ear62% | → $10 | Downgrade | Buy → Neutral | Get Alert |
| 11/08/2023 | Buy Now | 326.25% | Goldman Sachs | Salveen Richter52% | $56 → $63 | Maintains | Buy | Get Alert |
| 08/02/2023 | Buy Now | 102.98% | HC Wainwright & Co. | Patrick Trucchio51% | $90 → $30 | Maintains | Buy | Get Alert |
| 08/02/2023 | Buy Now | 184.17% | RBC Capital | Luca Issi45% | $47 → $42 | Maintains | Outperform | Get Alert |
| 08/02/2023 | Buy Now | 238.29% | Raymond James | Danielle Brill43% | $56 → $50 | Maintains | Outperform | Get Alert |
| 06/22/2023 | Buy Now | 82.68% | Chardan Capital | Matthew Barcus53% | $45 → $27 | Maintains | Buy | Get Alert |
| 06/21/2023 | Buy Now | 508.93% | HC Wainwright & Co. | Patrick Trucchio51% | → $90 | Reiterates | Buy → Buy | Get Alert |
| 05/19/2023 | Buy Now | 184.17% | UBS | Eliana Merle49% | $45 → $42 | Maintains | Buy | Get Alert |
| 05/16/2023 | Buy Now | 204.47% | Chardan Capital | Matthew Barcus53% | $56 → $45 | Maintains | Buy | Get Alert |
| 05/16/2023 | Buy Now | 278.89% | Raymond James | Danielle Brill43% | $58 → $56 | Maintains | Outperform | Get Alert |
| 05/11/2023 | Buy Now | 272.12% | Truist Securities | Robyn Karnauskas54% | $65 → $55 | Maintains | Buy | Get Alert |
| 05/10/2023 | Buy Now | 258.59% | RBC Capital | Luca Issi45% | → $53 | Reiterates | → Outperform | Get Alert |
| 03/07/2023 | Buy Now | 508.93% | HC Wainwright & Co. | Patrick Trucchio51% | → $90 | Reiterates | → Buy | Get Alert |
| 02/28/2023 | Buy Now | 258.59% | Guggenheim | Debjit Chattopadhyay55% | → $53 | Reiterates | → Buy | Get Alert |
| 02/28/2023 | Buy Now | 272.12% | Credit Suisse | Judah Frommer65% | $51 → $55 | Maintains | Outperform | Get Alert |
| 02/28/2023 | Buy Now | 305.95% | Chardan Capital | Matthew Barcus53% | → $60 | Reiterates | → Buy | Get Alert |
| 11/23/2022 | Buy Now | 184.17% | UBS | Eliana Merle49% | $40 → $42 | Maintains | Buy | Get Alert |
| 11/23/2022 | Buy Now | 285.66% | Goldman Sachs | Salveen Richter52% | $47 → $57 | Maintains | Buy | Get Alert |
| 11/03/2022 | Buy Now | 224.76% | Goldman Sachs | Julien Richer2% | $54 → $48 | Maintains | Buy | Get Alert |
| 08/09/2022 | Buy Now | 62.38% | Wells Fargo | Yanan Zhu43% | $34 → $24 | Maintains | Equal-Weight | Get Alert |
| 08/09/2022 | Buy Now | 305.95% | Chardan Capital | Matthew Barcus53% | $65 → $60 | Maintains | Buy | Get Alert |
FAQ
What is the target price for uniQure (QURE) stock?
The latest price target for uniQure (NASDAQ:QURE) was reported by Chardan Capital on May 30, 2025. The analyst firm set a price target for $38.00 expecting QURE to rise to within 12 months (a possible 157.10% upside). 30 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for uniQure (QURE)?
The latest analyst rating for uniQure (NASDAQ:QURE) was provided by Chardan Capital, and uniQure maintained their buy rating.
When was the last upgrade for uniQure (QURE)?
The last upgrade for uniQure NV happened on December 10, 2024 when Raymond James raised their price target to $52. Raymond James previously had an outperform for uniQure NV.
When was the last downgrade for uniQure (QURE)?
The last downgrade for uniQure NV happened on February 29, 2024 when Goldman Sachs changed their price target from $63 to $8 for uniQure NV.
When is the next analyst rating going to be posted or updated for uniQure (QURE)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of uniQure, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for uniQure was filed on May 30, 2025 so you should expect the next rating to be made available sometime around May 30, 2026.
Is the Analyst Rating uniQure (QURE) correct?
While ratings are subjective and will change, the latest uniQure (QURE) rating was a maintained with a price target of $38.00 to $38.00. The current price uniQure (QURE) is trading at is $14.78, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
